Items where authors include "Shaaban, AM"

Article

Bundred, N, Porta, N, Brunt, AM et al. (20 more authors) (2022) Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clinical Cancer Research. ISSN 1078-0432

Volpato, M orcid.org/0000-0002-7851-4533, Cummings, M, Shaaban, AM et al. (9 more authors) (2020) Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer. Exploration of Targeted Anti-tumor Therapy, 2020 (1). pp. 355-371. ISSN 2692-3114

Al Amri, WS, Allinson, LM, Baxter, DE orcid.org/0000-0001-8830-6802 et al. (7 more authors) (2020) Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer. Molecular Cancer Therapeutics, 19 (3). pp. 945-955. ISSN 1535-7163

Coulson-Gilmer, C, Humphries, MP, Sundara Rajan, S et al. (14 more authors) (2018) Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer. The Journal of Pathology: Clinical Research, 4 (4). pp. 241-249. ISSN 2056-4538

Lees, T, Cullinane, A, Condon, A et al. (3 more authors) (2018) Characterising the adipose-inflammatory microenvironment in male breast cancer. Endocrine-Related Cancer, 25 (7). pp. 773-781. ISSN 1351-0088

Pollard, J, Burns, PA, Hughes, TA orcid.org/0000-0003-1169-3386 et al. (7 more authors) (2018) Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities. Pathobiology, 85 (4). pp. 220-226. ISSN 1015-2008

Di Benedetto, A, Ercolani, C, Mottolese, M et al. (13 more authors) (2017) Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression. Scientific Reports, 7. 8078. ISSN 2045-2322

Di Benedetto, A, Mottolese, M, Sperati, F et al. (12 more authors) (2017) Association between AXL, Hippo transducers and survival outcomes in male breast cancer. Journal of Cellular Physiology, 232 (8). pp. 2246-2252. ISSN 0021-9541

Humphries, MP orcid.org/0000-0003-1306-7012, Rajan, SS, Droop, A orcid.org/0000-0001-7695-7480 et al. (29 more authors) (2017) A Case Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic and Tractable Biomarkers in Male Breast Cancer. Clinical Cancer Research, 23 (10). pp. 2575-2583. ISSN 1078-0432

Humphries, MP orcid.org/0000-0003-1306-7012, Sundara Rajan, S, Honarpisheh, H et al. (18 more authors) (2017) Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Scientific Reports, 7. 45293. ISSN 2045-2322

Di Benedetto, A, Mottolese, M, Sperati, F et al. (12 more authors) (2016) HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes. Scientific Reports, 6. 35121. ISSN 2045-2322

Di Benedetto, A, Mottolese, M, Sperati, F et al. (12 more authors) (2016) The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer. Oncotarget, 7 (28). pp. 43188-43198. ISSN 1949-2553

Fatayer, H, Sharma, N, Manuel, D et al. (7 more authors) (2016) Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment. European Journal of Surgical Oncology, 42 (7). pp. 965-972. ISSN 0748-7983

Gahlaut, R, Bennett, A, Fatayer, H et al. (7 more authors) (2016) Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist. European journal of cancer, 60. pp. 40-48. ISSN 0959-8049

Speirs, V, Viale, G, Mousa, K et al. (14 more authors) (2015) Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES) - first results from PathIES. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. ISSN 0923-7534

Shaaban, AM, Green, AR, Karthik, S et al. (9 more authors) (2008) Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients. Clinical Cancer Research, 14 (16). pp. 5228-5235. ISSN 1078-0432